Skip to main content
Premium Trial:

Request an Annual Quote

Funding Update: NIH Grants Awarded to Ohio State, Vanderbilt, and More

Premium

NIH Grants in Proteomics, October 5 to November 14

Project Title: Mass Spectrometry, Proteomics and Metabolomics Core
Organization Name: Brigham and Women's Hospital
Contact Principal Investigator: John Asara
Project Start Date: April 1, 2006
Project End Date: July 31, 2017
FY Total Cost: $192,781


Project Title: Bioanalytical/Mass Spectrometry/Proteomics Core
Organization Name: Vanderbilt University Medical Center
Contact Principal Investigator: Richard Caprioli
Project Start Date: Dec. 1, 2000
Project End Date: May 31, 2017
FY Total Cost: $88,117


Project Title: Suppression of Mammary Tumorigenesis by Stromal P53
Organization Name: Ohio State University
Contact Principal Investigator: Gustavo Leone
Project Start Date: Dec. 1, 2011
Project End Date: May 31, 2017
FY Total Cost: $301,062


Project Title: Bioanalytical Laboratory
Organization Name: Wake Forest University Health Sciences
Contact Principal Investigator: Mark Lively
Project Start Date: Feb. 1, 1997
Project End Date: Jan. 31, 2017
FY Total Cost: $84,837


Project Title: Pharmacology and Analytic
Organization Name: University of Texas MD Anderson Cancer Center
Contact Principal Investigator: Timothy Madden
Project Start Date: NA
Project End Date: NA
FY Total Cost: $2,882


Project Title: Mechanisms Determining Stromal PTEN Suppression of Iviammary Tumorigenesis
Organization Name: Ohio State University
Contact Principal Investigator: Michael Ostrowski
Project Start Date: Dec. 1, 2011
Project End Date: May 31, 2017
FY Total Cost: $301,069


Project Title: Genomics and Proteomics
Organization Name: Cold Spring Harbor Laboratory
Contact Principal Investigator: Scott Powers
Project Start Date: Jan. 1, 2012
Project End Date: Dec. 31, 2016
FY Total Cost: $443,355


Project Title: Comparative Pathology Core
Organization Name: Ohio State University
Contact Principal Investigator: Thomas Rosol
Project Start Date: Dec. 1, 2011
Project End Date: May 31, 2017
FY Total Cost: $187,393


Project Title: Long Nuclear-Retained Non-Coding RNAs and Cancer
Organization Name: Cold Spring Harbor Laboratory
Contact Principal Investigator: David Spector
Project Start Date: Jan. 1, 2012
Project End Date: Dec. 31, 2016
FY Total Cost: $432,183


Project Title: Innate Immune Gene Profiling Core
Organization Name: University of North Carolina Chapel Hill
Contact Principal Investigator: Jenny Ting
Project Start Date: March 1, 2008
Project End Date: Feb. 28, 2013
FY Total Cost: $147,129

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.